11/9/2005

Concerns about an avian flu pandemic, bioterrorism and other public health threats are prompting legislators to encourage pharmaceutical firms to develop and produce more medicines needed by the public. The Wall Street Journal examines some of the proposals under consideration.

Related Summaries